Related Experiment Video
Updated: Oct 9, 2025

09:14
Pre-Chiasmatic, Single Injection of Autologous Blood to Induce Experimental Subarachnoid Hemorrhage in a Rat Model
Published on: June 18, 2021
2.5K
Diffuse Angiogram-Negative Subarachnoid Hemorrhage is Associated with an Intermediate Clinical Course
Feras Akbik1,2, Cederic Pimentel-Farias3,4, Di'Jonai A Press5,4
1Division of Neurocritical Care, Departments of Neurology and Neurosurgery, Emory University School of Medicine, 1364 Clifton Rd NE, Atlanta, GA, 30322, USA. feras.akbik@gmail.com.
Neurocritical Care
|December 21, 2021
Summary
Diffuse subarachnoid hemorrhage (SAH) has a worse prognosis than perimesencephalic SAH but is less severe than aneurysmal SAH. This finding highlights the need for vigilant acute care for diffuse SAH patients.
Area of Science:
- Neurology
- Neurosurgery
- Critical Care Medicine
Background:
- Nontraumatic subarachnoid hemorrhage (SAH) can be angiogram-negative in 15-20% of cases.
- These angiogram-negative cases include perimesencephalic SAH and diffuse SAH.
- Perimesencephalic SAH is generally considered to have a better prognosis than diffuse SAH.
Purpose of the Study:
- To compare the clinical course and functional outcomes of perimesencephalic SAH, diffuse SAH, and aneurysmal SAH.
- To better characterize the prognostic implications of each SAH subtype.
Main Methods:
- Retrospective cohort study of nontraumatic SAH patients admitted between 2012 and 2017.
- Patients were categorized into perimesencephalic SAH, diffuse SAH, and aneurysmal SAH groups based on radiographic bleed patterns.
- Demographics, complications, and clinical outcomes were analyzed and compared across the three groups.
Main Results:
- Aneurysmal SAH patients were more likely to be female, White, and active smokers.
- Critical care complications like hypotension, shock, and endotracheal intubation were significantly higher in diffuse SAH and aneurysmal SAH groups compared to perimesencephalic SAH.
- Diffuse SAH patients experienced intermediate functional outcomes, with higher rates of nonhome discharge and poor functional status than perimesencephalic SAH, but lower than aneurysmal SAH.
Conclusions:
- Perimesencephalic SAH is associated with a benign clinical course.
- Diffuse SAH confers an intermediate prognosis, more severe than perimesencephalic SAH but less so than aneurysmal SAH.
- Vigilant acute care and high-acuity observation are crucial for patients with diffuse SAH to mitigate morbidity and neurologic compromise.

